Education
About Us
Working with TipRanks
Follow Us
Guard Therapeutics International AB (SE:GUARD)
:GUARD
RESEARCH TOOLSreports
Summary of all the Indicators
Overall Consensus
Strong Buy
15Bullish
5Neutral
2Bearish
Technical Analysis Consensus
Neutral
3Bullish
5Neutral
2Bearish
Moving Average Consensus
Strong Buy
12Bullish
0Neutral
0Bearish
Guard Therapeutics International AB’s (GUARD) Moving Averages Convergence Divergence (MACD) indicator is 1.19, suggesting Guard Therapeutics International AB is a Sell.
Guard Therapeutics International AB’s (GUARD) 20-Day exponential moving average is 21.83, while Guard Therapeutics International AB’s (GUARD) share price is kr23.4, making it a Buy.
Guard Therapeutics International AB’s (GUARD) 50-Day exponential moving average is 20.00, while Guard Therapeutics International AB’s (GUARD) share price is kr23.4, making it a Buy.
Guard Therapeutics International AB (GUARD) Pivot Points
Classic
20.90
21.70
22.40
23.20
23.90
24.70
25.40
Fibonacci
21.70
22.27
22.63
23.20
23.77
24.13
24.70
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.
Guard Therapeutics International AB (GUARD) Moving Averages
MA5
23.08Buy
23.15Buy
MA10
23.07Buy
22.74Buy
MA20
21.59Buy
21.83Buy
MA50
19.44Buy
20.00Buy
MA100
17.11Buy
19.05Buy
MA200
18.78Buy
20.17Buy
Guard Therapeutics International AB’s (GUARD) 10-Day exponential moving average is 22.74, while Guard Therapeutics International AB’s (GUARD) share price is kr23.4, making it a Buy.
Guard Therapeutics International AB’s (GUARD) 100-Day exponential moving average is 19.05, while Guard Therapeutics International AB’s (GUARD) share price is kr23.4, making it a Buy.
Guard Therapeutics International AB’s (GUARD) stock price is kr23.4 and Guard Therapeutics International AB’s (GUARD) 50-day simple moving average is 19.44, creating a Buy signal.
Guard Therapeutics International AB’s (GUARD) stock price is kr23.4 and Guard Therapeutics International AB’s (GUARD) 100-day simple moving average is 17.11, creating a Buy signal.
Guard Therapeutics International AB’s (GUARD) stock price is kr23.4 and Guard Therapeutics International AB’s (GUARD) 200-day simple moving average is 18.78, creating a Buy signal.
Guard Therapeutics International AB (GUARD) Technical Indicators
RSI (14)
65.57
Neutral
STOCH (9,6)
53.43
Neutral
STOCHRSI (14)
74.37
Neutral
MACD (12,26)
1.19
Sell
ADX (14)
50.24
Sell
Williams %R
-23.85
Buy
CCI (14)
68.52
Neutral
ATR (14)
1.34
-
Ultimate Oscillator
53.23
Neutral
ROC
20.31
Buy
Guard Therapeutics International AB’s (GUARD) Relative Strength Index (RSI) is 65.57, creating a Neutral signal.
Guard Therapeutics International AB’s (GUARD) Trend Strength Indicator (ADX) is 50.24, creating a Sell signal.
Guard Therapeutics International AB’s (GUARD) Commodity Channel Index (CCI) is 68.52, creating a Neutral signal.
Guard Therapeutics International AB’s (GUARD) Price Rate of Change (ROC) is 20.31, creating a Buy signal.
FAQ
Is GUARD a Buy, Hold, or Sell?
Based on GUARD’s technical indicators, GUARD is a Strong Buy.
What is GUARD’s RSI (14)?
GUARD’s RSI (14) is 65.57, which suggests GUARD is a Neutral.
What is GUARD’s MACD?
GUARD’s MACD is 1.19, which suggests GUARD is a Sell.
What is GUARD’s 5-day moving average?
GUARD’s 5-day moving average is 23.08, which suggests GUARD is a Buy.
What is GUARD’s 20-day moving average?
GUARD 20-day moving average is 21.59, which suggests GUARD is a Buy.
What is GUARD’s 50-day moving average?
GUARD’s 50-day moving average is 19.44, which suggests GUARD is a Buy.
What is GUARD’s 200-day moving average?
GUARD’s 200-day moving average is 18.78, which suggests GUARD is a Buy.
What is GUARD’s Williams % R (14)?
GUARD’s Williams % R (14) is -23.85, which suggests GUARD is a Buy.
What is GUARD’s CCI (14)?
GUARD’s CCI (14) is 68.52, which suggests GUARD is a Neutral.
What is the share price of Guard Therapeutics International AB?